---
figid: PMC6274888__ijms-19-03584-g001
figlink: /pmc/articles/PMC6274888/figure/ijms-19-03584-f001/
number: F1
caption: The response to immunotherapy in pancreatic ductal adenocarcinoma (PDAC)
  relies on destroying cancer cells as well as on breaking the stromal barrier and
  flaring up immune function. Immunotherapy targeting the PD-1/PD-L1 pathway and TME
  has disrupted the traditional method of cancer treatment and countered the immune-related
  adverse events in patients. In addition to direct cytotoxicity on cancer cells,
  it is important to dissect the immunosuppressive microenvironment with various cytokines
  and immune cells. Furthermore, recognition of mechanisms modulating the PD-1/PD-L1
  pathway and TME will identify more potential therapeutic targets in the future.
pmcid: PMC6274888
papertitle: 'From Friend to Enemy: Dissecting the Functional Alteration of Immunoregulatory
  Components during Pancreatic Tumorigenesis.'
reftext: Hui-Ching Wang, et al. Int J Mol Sci. 2018 Nov;19(11):3584.
pmc_ranked_result_index: '19635'
pathway_score: 0.8663284
filename: ijms-19-03584-g001.jpg
figtitle: Response to immunotherapy in pancreatic ductal adenocarcinoma (PDAC) relies
  on destroying cancer cells as well as on breaking the stromal barrier and flaring
  up immune function
year: '2018'
organisms:
- Homo sapiens
ndex: f87be5fc-dea9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6274888__ijms-19-03584-g001.html
  '@type': Dataset
  description: The response to immunotherapy in pancreatic ductal adenocarcinoma (PDAC)
    relies on destroying cancer cells as well as on breaking the stromal barrier and
    flaring up immune function. Immunotherapy targeting the PD-1/PD-L1 pathway and
    TME has disrupted the traditional method of cancer treatment and countered the
    immune-related adverse events in patients. In addition to direct cytotoxicity
    on cancer cells, it is important to dissect the immunosuppressive microenvironment
    with various cytokines and immune cells. Furthermore, recognition of mechanisms
    modulating the PD-1/PD-L1 pathway and TME will identify more potential therapeutic
    targets in the future.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GLI1
  - CXCL2
  - TGFB1
  - CXCL13
  - VEGFA
  - VEGFC
  - CXCR4
  - CXCL3
  - CXCL1
  - CTLA4
  - CXCL9
  - PF4
  - CXCL8
  - CXCL10
  - ARG1
  - PPBP
  - CXCL14
  - CD274
  - VEGFD
  - PGF
  - SHH
  - VEGFB
  - TGFB2
  - TGFB3
  - CXCL5
  - CXCL12
  - CXCL6
  - CXCL11
  - ATRA
  - pexidartinib
  - lenalidomide
  - acalabrutinib
  - paricalcitol
  - paclitaxel
  - cyclophosphamide
  - ARG
  - gemcitabine
genes:
- word: SHH,GLI1,VEGF
  symbol: GLI1
  source: hgnc_symbol
  hgnc_symbol: GLI1
  entrez: '2735'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL2
  entrez: '2920'
- word: TGF-B,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL13
  entrez: '10563'
- word: SHH,GLI1,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: SHH,GLI1,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: CXCR4
  symbol: CXCR4
  source: hgnc_symbol
  hgnc_symbol: CXCR4
  entrez: '7852'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL3
  entrez: '2921'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL1
  entrez: '2919'
- word: CTLA-4/PD-L1
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PF4
  entrez: '5196'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: ARG-1,
  symbol: ARG1
  source: hgnc_symbol
  hgnc_symbol: ARG1
  entrez: '383'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PPBP
  entrez: '5473'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL14
  entrez: '9547'
- word: CTLA-4/PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: SHH,GLI1,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: SHH,GLI1,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: SHH,
  symbol: SHH
  source: hgnc_symbol
  hgnc_symbol: SHH
  entrez: '6469'
- word: SHH,GLI1,VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: TGF-B,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL5
  entrez: '6374'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL6
  entrez: '6372'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL11
  entrez: '6373'
chemicals:
- word: ATRA
  source: MESH
  identifier: D014212
- word: pexidartinib
  source: ''
  identifier: ''
- word: lenalidomide
  source: MESH
  identifier: C467567
- word: acalabrutinib
  source: ''
  identifier: ''
- word: paricalcitol
  source: MESH
  identifier: C084656
- word: paclitaxel
  source: MESH
  identifier: D017239
- word: cyclophosphamide
  source: MESH
  identifier: D003520
- word: ARG
  source: MESH
  identifier: C545206
- word: gemcitabine
  source: MESH
  identifier: C056507
diseases: []
figid_alias: PMC6274888__F1
redirect_from: /figures/PMC6274888__F1
figtype: Figure
---
